Aplastic Anemia
📧 Sign up to get email alerts when something new happens for Aplastic Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Avatrombopag Combined With IST as First-line Treatment for SAA [Phase 2]
Phase 2 clinical trial update exploring avatrombopag plus IST as first-line therapy for severe aplastic anemia.
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients [Phase 2]
Phase 2 trial evaluating the efficacy and safety of eltrombopag plus tacrolimus in Chinese patients with refractory or relapsed aplastic ane…
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: GVHD Prophylaxis by Addition of CD20 Monoclonal Antibody to the Conditioning Regimen in SAA With Treatment of Allo-HSCT [Phase 2]
Phase 2 trial evaluating adding a CD20 monoclonal antibody to conditioning for GVHD prophylaxis in allogeneic stem cell transplant for aplas…
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia （SAA） Patient [Phase 1, Phase 2]
A clinical trial evaluating the safety and efficacy of hetrombopag olamine in patients with severe aplastic anemia has completed Phase 1 and…
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) [Phase 2]
This Phase 2 trial update reports results from the haploidentical transplantation approach studied in BMT CTN 1502 for severe aplastic anemi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia [Phase 2]
Phase 2 trial update on haploidentical or matched unrelated donor bone marrow transplantation for newly diagnosed severe aplastic anemia; re…
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis [Phase 2]
Phase 2 clinical trial update on post-transplant cyclophosphamide for graft-versus-host disease prophylaxis completed; results posted in 202…
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: Study of AMG531(Romiplostim) in Patients With Aplastic Anemia [Phase 2, Phase 3]
Phase 2/3 trial updates for romiplostim (AMG531) in patients with aplastic anemia have been completed.
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia [Phase 2, Phase 3]
Phase 2/3 trial evaluating romiplostim (AMG531) in patients with aplastic anemia has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic Anemia [Phase 3]
Phase 3 trial assessing PF-06462700 in Japanese participants with aplastic anemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Eltrombopag & Cyclosporine in Children With Sever Aplastic Anemia [Phase 4]
A Phase 4 clinical trial update examining eltrombopag in combination with cyclosporine for children with severe aplastic anemia has been com…
-
CLINICAL_TRIALS trial_result · 2021-10-18Clinical Trial Update: Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia [Phase 2]
Phase 2 trial evaluating rabbit antithymocyte globulin (Thymoglobuline) with Ciclosporin for acquired aplastic anaemia has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic Anaemia [Phase 4]
A Phase 4 clinical trial evaluating a combination of a thrombopoietin mimetic and immunosuppressive therapy in aplastic anemia has been comp…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia [Phase 2, Phase 3]
Clinical trial update on hetrombopag for non-severe aplastic anemia across Phase 2 and Phase 3 assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia [Phase 2]
Phase 2 clinical trial evaluating improved immunosuppressive treatment for severe aplastic anemia has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: Unrelated Umbilical Cord Blood (UBC)Transplantation [NA]
Clinical trial update for unrelated umbilical cord blood transplantation; the study is completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Combination Therapy of Severe Aplastic Anemia [Phase 2]
Phase 2 trial update on a combination therapy for severe aplastic anemia.
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia [Phase 2]
A Phase 2 study evaluating AMG531 in patients with aplastic anemia has completed with results posted in February 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Avatrombopag Usage in NSAA [Phase 2, Phase 3]
Phase 2/3 trial update for avatrombopag in aplastic anemia with drug effect considerations; current status unknown.
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders [Phase 2]
Phase 2 trial evaluating a conditioning regimen followed by donor bone marrow or stem cell transplant in patients with primary immunodeficie…
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome [Phase 2]
Phase IIA open-label study to evaluate BL-8040 followed by immunosuppressive therapy in adults with aplastic anemia or hypoplastic myelodysp…
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: Comparing Therapies for the Treatment of Severe Aplastic Anemia [Phase 2]
Phase 2 clinical trial update comparing therapies for severe aplastic anemia has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: A Novel TBI Free Conditioning Protocol for Haploidentical Transplant in Acquired Aplastic Anemia: [Phase 2]
Phase 2 clinical trial evaluating a novel TBI-free conditioning protocol for haploidentical transplant in acquired aplastic anemia.
-
CLINICAL_TRIALS trial_result · 2020-07-31Clinical Trial Update: Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating a stem cell transplant using peripheral and cord blood stem cells for severe aplastic anemia and myelodysp…
-
CLINICAL_TRIALS trial_result · 2020-06-05Clinical Trial Update: Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia [Phase 1, Phase 2]
Clinical trial update of eltrombopag with standard immunosuppression for severe aplastic anemia. The Phase 1/2 study had results posted in 2…